Radiomic Analysis to Predict Outcome in Recurrent Glioblastoma Based on Multi-Center MR Imaging From the Prospective DIRECTOR Trial

BACKGROUND: Based on promising results from radiomic approaches to predict O(6)-methylguanine DNA methyltransferase promoter methylation status (MGMT status) and clinical outcome in patients with newly diagnosed glioblastoma, the current study aimed to evaluate radiomics in recurrent glioblastoma pa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Vils, Alex, Bogowicz, Marta, Tanadini-Lang, Stephanie, Vuong, Diem, Saltybaeva, Natalia, Kraft, Johannes, Wirsching, Hans-Georg, Gramatzki, Dorothee, Wick, Wolfgang, Rushing, Elisabeth, Reifenberger, Guido, Guckenberger, Matthias, Weller, Michael, Andratschke, Nicolaus
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079773/
https://ncbi.nlm.nih.gov/pubmed/33937035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.636672
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi